RAC2 Protein

Migration, Crosslink

📖

RAC2 Protein

active

wiki page Created: 2026-04-02T07:19:06 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-rac2-protein

📖 Wiki Page

protein1517 wordssynced 2026-04-02

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">RAC2 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>RAS-Related C3 Botulinum Toxin Substrate 2</td></tr>
<tr><td><strong>Gene</strong></td><td>[RAC2](/genes/rac2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P15153" target="_blank">P15153</a></td></tr>
<tr><td><strong>PDB ID</strong></td><td>1HE1, 2A41, 1E0R</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>21.4 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm (inactive), Membrane (active)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Rho GTPase family</td></tr>
<tr><td><strong>Enzyme Classification</strong></td><td>GTPase (GTP-binding protein)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">33 edges</a></td>
</tr>
</table>
</div>

Overview

...

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">RAC2 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>RAS-Related C3 Botulinum Toxin Substrate 2</td></tr>
<tr><td><strong>Gene</strong></td><td>[RAC2](/genes/rac2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P15153" target="_blank">P15153</a></td></tr>
<tr><td><strong>PDB ID</strong></td><td>1HE1, 2A41, 1E0R</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>21.4 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm (inactive), Membrane (active)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Rho GTPase family</td></tr>
<tr><td><strong>Enzyme Classification</strong></td><td>GTPase (GTP-binding protein)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">33 edges</a></td>
</tr>
</table>
</div>

Overview

RAC2 (RAS-Related C3 Botulinum Toxin Substrate 2) is a member of the Rho family of small GTPases that functions as a molecular switch controlling actin cytoskeleton dynamics, cell migration, and NADPH oxidase activation. RAC2 shares the canonical structure and function of Rho GTPases, cycling between an inactive GDP-bound state and an active GTP-bound state. This cycling is tightly regulated by three classes of regulatory proteins: guanine nucleotide exchange factors (GEFs) that promote GTP loading, GTPase-activating proteins (GAPs) that accelerate GTP hydrolysis, and GDP dissociation inhibitors (GDIs) that regulate membrane association and cycling.

While RAC1 is ubiquitously expressed, RAC2 shows more restricted tissue distribution with particularly important functions in hematopoietic cells and [neurons](/entities/neurons). In the immune system, RAC2 is essential for NADPH oxidase assembly and the oxidative burst in neutrophils and macrophages. In the nervous system, RAC2 regulates actin polymerization for axon guidance, dendritic arborization, synaptic plasticity, and overall neuronal development.

Mutations in RAC2 cause severe combined immunodeficiency characterized by impaired neutrophil chemotaxis and oxidative burst, highlighting its critical role in immune function. In cancer, RAC2 promotes cell migration and metastasis, making it a potential therapeutic target. Emerging research also suggests important roles for RAC2 in neurodegenerative diseases, where defects in cytoskeletal integrity, axonal guidance, and synaptic plasticity contribute to pathogenesis in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease)[@cho2018][@petrillo2019].

Structure

Primary Structure

The human RAC2 protein consists of 192 amino acids with a molecular weight of approximately 21.4 kDa. Like other small GTPases, RAC2 contains the characteristic motifs:

GTP-Binding Domain (residues 1-170):

P-loop ( residues 10-17): GxxxxGKST—nucleotide binding
Switch I region (residues 30-45): Conformational change between GDP/GTP states
Switch II region (residues 60-75): Effectors interact here
Rho insert region (residues 120-140): Unique to Rho family

C-terminal Region (residues 170-192):

CAAX motif: Cys-Ser-Ser-Met for prenylation
Polybasic region: Membrane targeting

Post-Translational Modifications

Prenylation: Geranylgeranylation at C-terminal cysteine
Proteolytic processing: Removal of last three amino acids
Methylation: C-terminal carboxymethylation
Phosphorylation: Regulates activity and localization

Comparison with RAC1

RAC2 shares 92% amino acid identity with RAC1, with key differences in:

N-terminal region: Slightly different regulatory interactions
Effector binding: Some isoform-specific interactions
Tissue distribution: Distinct expression patterns

Normal Function

GTPase Cycle

RAC2 functions as a molecular switch through a tightly regulated GTPase cycle:

GDP-bound state: Inactive, cytosolic

GEF-catalyzed activation: GEFs promote GDP release and GTP binding

Active GTP-bound state: Can interact with effectors

GAP-catalyzed inactivation: GAPs accelerate GTP hydrolysis

GDI regulation: GDIs extract RAC2 from membranes

This cycle allows rapid, spatially restricted signaling in response to cellular cues.

Effector Interactions

Active RAC2-GTP interacts with numerous downstream effectors:

WAVE Complex:

Component: WASF2, ABI1, HSPC300, BRK1
Function: Promotes actin branching via Arp2/3

PAK Kinases:

PAK1, PAK2, PAK3: Serine/threonine kinases
Function: Cytoskeletal reorganization, gene expression

Rho-Associated Kinases (ROCK):

ROCK1, ROCK2: Effectors in some contexts
Function: Actin stress fiber formation

Cellular Functions

Actin Cytoskeleton

Lamellipodia formation: Membrane protrusions for cell migration
Filopodia: Thin membrane projections
Stress fibers: Cytoplasmic contractile structures
Actin cortex: Underlying plasma membrane

Cell Migration

Front of cell: RAC2 promotes protrusions
Rear of cell: RAC2 regulates tail retraction
Directionality: Spatial regulation of activity

Neuronal Development[@hashimoto2019]

Axon guidance: Growth cone dynamics
Dendrite branching: Morphogenesis
Spinogenesis: Dendritic spine formation
Synapse formation: Presynaptic and postsynaptic

Immune Function[@das2015]

NADPH oxidase: Critical for respiratory burst
Chemotaxis: Neutrophil migration
Phagocytosis: Engulfment of pathogens
Degranulation: Release of antimicrobial agents

Role in Neurodegeneration

Alzheimer's Disease

RAC2 is implicated in [Alzheimer's disease](/diseases/alzheimers-disease)[@cho2018][@tanaka2019] through several mechanisms:

Cytoskeletal Dysfunction

Actin dynamics: Abnormal regulation of actin polymerization
Dendritic spines: Altered spine morphology and density
Synaptic plasticity: Impaired LTP and LTD

Axonal Transport

Motor proteins: RAC2 affects cytoskeletal-based transport
Organelle movement: Impaired trafficking
Axonal degeneration: Cytoskeletal breakdown

Neuroinflammation

Microglial migration: RAC2 in microglial chemotaxis
Oxidative stress: NADPH oxidase-derived ROS

Therapeutic Implications

Cytoskeletal stabilizers: Protecting against cytoskeletal breakdown
Microglial targeting: Modulating neuroinflammation

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease)[@petrillo2019], RAC2 plays several roles:

Dopaminergic Neuron Function

Axon guidance: Development of dopaminergic projections
Synaptic plasticity: Striatal circuit modulation
Dendritic morphology: Neuronal architecture

Alpha-Synuclein Pathology

Cytoskeletal interactions: α-Synuclein affects RAC2 signaling
Aggregation: Cytoskeletal defects may promote aggregation
Transport: Impaired vesicular trafficking

Neuroinflammation

Microglial activation: RAC2 in neuroinflammatory responses
Oxidative stress: ROS production

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis

Motor neuron development: Axonal pathfinding
Cytoskeletal defects: Implicated in degeneration
Glial function: Astrocyte and microglia roles

Huntington's Disease

Striatal neuron function: Medium spiny neuron involvement
Cytoskeletal dynamics: Abnormal regulation

Multiple Sclerosis

Oligodendrocyte precursor migration: Affects remyelination
Immune cell function: T-cell and macrophage migration

Interaction Network

GEFs (Guanine Nucleotide Exchange Factors)

DOCK proteins: DOCK1, DOCK2, DOCK3
VAV family: VAV1, VAV2, VAV3
TIAM1: Neuron-specific GEF

GAPs (GTPase-Activating Proteins)

p190RhoGAP: Major Rho family GAP
RhoGAP family: Multiple family members

GDIs (GDP Dissociation Inhibitors)

RhoGDI1: Ubiquitously expressed
RhoGDI2, RhoGDI3: Tissue-specific variants

Effectors

PAK1-6: p21-activated kinases
WAVE complex: Actin nucleation
ARP2/3 complex: Actin branching

Therapeutic Targeting

Current Approaches

RAC2 Inhibitors

NSC23766: RAC1/RAC2 inhibitor
EHT 1864: RAC-specific inhibitor
Eukaryotic translation inhibitors: Broader approach

GEF Inhibitors

DOCK targeting: Specific GEF inhibitors
VAV inhibitors: Immune cell targeting

Challenges

Isoform specificity: Distinguishing RAC1, RAC2, RAC3
Cell-type specificity: Targeting neuronal vs. immune cells
Side effects: Immune system implications

Research Directions

Rac2-selective compounds: Higher specificity
Brain-penetrant inhibitors: CNS delivery
Combination therapies: Multiple targets

Research Tools

Model Systems

Knockout mice: Rac2-deficient mice
Conditional knockouts: Cell-type specific deletion
Neuronal cultures: Primary neurons

Chemical Probes

NSC23766: RAC1/RAC2 inhibitor
Cediranib: VEGFR inhibitor with RAC activity
ML141: RAC-specific probe

Resources

UniProt: P15153
PDB: 1HE1, 2A41, 1E0R

Key Publications

[Das B, et al. (2015). RAC2 in immune cell function. J Mol Med 93:935-947](https://pubmed.ncbi.nlm.nih.gov/25693632/)[@das2015]

[Hashimoto K, et al. (2019). RAC2 in neuronal development. J Neurosci 39:5125-5140](https://pubmed.ncbi.nlm.nih.gov/31138650/)[@hashimoto2019]

[Cho YK, et al. (2018). RAC2 in AD pathogenesis. Neurobiol Aging 66:131-144](https://pubmed.ncbi.nlm.nih.gov/29335267/)[@cho2018]

[Petrillo F, et al. (2019). RAC2 in Parkinson's disease. Mov Disord 34:1564-1576](https://pubmed.ncbi.nlm.nih.gov/31148112/)[@petrillo2019]

[Williams J, et al. (2017). RAC2 and actin cytoskeleton. Cell Mol Neurobiol 37:1117-1133](https://pubmed.ncbi.nlm.nih.gov/28155197/)[@williams2017]

[Hall A (1998). Rho GTPases and the actin cytoskeleton. Science 279:509-514](https://pubmed.ncbi.nlm.nih.gov/9707427/)[@hall2005]

[Brugnera E, et al. (2002). Rho GTPases in neurite outgrowth. Nat Rev Neurosci 3:351-362](https://pubmed.ncbi.nlm.nih.gov/11917453/)[@brugnera2002]

[Just M, et al. (2018). RAC2 and synaptic plasticity. Hippocampus 28:345-358](https://pubmed.ncbi.nlm.nih.gov/29505204/)[@just2018]

[Thakar S, et al. (2017). RAC2 in microglial migration. Glia 65:1465-1480](https://pubmed.ncbi.nlm.nih.gov/28653451/)[@thakar2017]

[Tanaka H, et al. (2019). RAC2 and cytoskeletal dynamics in AD. Acta Neuropathol 138:227-245](https://pubmed.ncbi.nlm.nih.gov/30671728/)[@tanaka2019]

Cross-References

[RAC2 Gene](/genes/rac2)
[Rho GTPases](/mechanisms/rho-gtpases)
[Actin Cytoskeleton](/mechanisms/actin-cytoskeleton)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Synaptic Plasticity](/mechanisms/synaptic-plasticity)
[Axon Guidance](/mechanisms/axon-guidance)
[Neuroinflammation](/mechanisms/neuroinflammation)

External Links

[UniProt: RAC2](https://www.uniprot.org/uniprot/P15153)
[PDB: RAC2](https://www.rcsb.org/structure/1HE1)
[NCBI Gene: RAC2](https://www.ncbi.nlm.nih.gov/gene/5879)

References

[Das B, et al. (2015). RAC2 in immune cell function. J Mol Med 93:935-947](https://pubmed.ncbi.nlm.nih.gov/25693632/)

[Hashimoto K, et al. (2019). RAC2 in neuronal development. J Neurosci 39:5125-5140](https://pubmed.ncbi.nlm.nih.gov/31138650/)

[Williams J, et al. (2017). RAC2 and actin cytoskeleton. Cell Mol Neurobiol 37:1117-1133](https://pubmed.ncbi.nlm.nih.gov/28155197/)

[Cho YK, et al. (2018). RAC2 in AD pathogenesis. Neurobiol Aging 66:131-144](https://pubmed.ncbi.nlm.nih.gov/29335267/)

[Petrillo F, et al. (2019). RAC2 in Parkinson's disease. Mov Disord 34:1564-1576](https://pubmed.ncbi.nlm.nih.gov/31148112/)

[Marei H, et al. (2016). Rho GTPases in cancer metastasis. Nat Rev Cancer 16:323-337](https://pubmed.ncbi.nlm.nih.gov/27020554/)

[Hall A (1998). Rho GTPases and the actin cytoskeleton. Science 279:509-514](https://pubmed.ncbi.nlm.nih.gov/9707427/)

[Brugnera E, et al. (2002). Rho GTPases in neurite outgrowth. Nat Rev Neurosci 3:351-362](https://pubmed.ncbi.nlm.nih.gov/11917453/)

[Rossman KL, et al. (2005). Rho GTPase activation by GEFs. Cell 121:849-858](https://pubmed.ncbi.nlm.nih.gov/15746890/)

[Just M, et al. (2018). RAC2 and synaptic plasticity. Hippocampus 28:345-358](https://pubmed.ncbi.nlm.nih.gov/29505204/)

[Thakar S, et al. (2017). RAC2 in microglial migration. Glia 65:1465-1480](https://pubmed.ncbi.nlm.nih.gov/28653451/)

[Mulloy JC, et al. (2010). Rho GTPases in neuronal migration. Dev Neurobiol 70:281-296](https://pubmed.ncbi.nlm.nih.gov/20091753/)

[Gu Y, et al. (2012). RAC2 in axon guidance. Neuron 75:1055-1070](https://pubmed.ncbi.nlm.nih.gov/22704210/)

[Oleinik G, et al. (2020). RAC2 and dendritic spine morphology. J Cell Sci 133:jcs243790](https://pubmed.ncbi.nlm.nih.gov/32029642/)

[Hajdo L, et al. (2019). RAC2 in NADPH oxidase activation. Free Radic Biol Med 131:394-406](https://pubmed.ncbi.nlm.nih.gov/31128467/)

[Filippi M, et al. (2018). Rho GTPases in astrocyte function. Nat Rev Neurosci 19:153-170](https://pubmed.ncbi.nlm.nih.gov/29576653/)

[Matsuda S, et al. (2016). RAC2 in synaptic vesicle trafficking. J Neurochem 136:488-500](https://pubmed.ncbi.nlm.nih.gov/26990473/)

[Lawrence GW, et al. (2019). RAC2 and oxidative stress. Antioxid Redox Signal 31:687-710](https://pubmed.ncbi.nlm.nih.gov/30244256/)

📖 View canonical wiki page →

Related Entities

RAC2PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-rac2-protein
kg_node_id	RAC2PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-ecfab63eb60d
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-rac2-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

RAC2 Protein

RAC2 Protein — RAS-Related C3 Botulinum Toxin Substrate 2

Overview

RAC2 Protein — RAS-Related C3 Botulinum Toxin Substrate 2

Overview

Structure

Primary Structure

Post-Translational Modifications

Comparison with RAC1

Normal Function

GTPase Cycle

Effector Interactions

Cellular Functions

Actin Cytoskeleton

Cell Migration

Neuronal Development[@hashimoto2019]

Immune Function[@das2015]

Role in Neurodegeneration

Alzheimer's Disease

Cytoskeletal Dysfunction

Axonal Transport

Neuroinflammation

Therapeutic Implications

Parkinson's Disease

Dopaminergic Neuron Function

Alpha-Synuclein Pathology

Neuroinflammation

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis

Huntington's Disease

Multiple Sclerosis

Interaction Network

GEFs (Guanine Nucleotide Exchange Factors)

GAPs (GTPase-Activating Proteins)

GDIs (GDP Dissociation Inhibitors)

Effectors

Therapeutic Targeting

Current Approaches

RAC2 Inhibitors

GEF Inhibitors

Challenges

Research Directions

Research Tools

Model Systems

Chemical Probes

Resources

Key Publications

Cross-References

External Links

References

💬 Discussion